Literature DB >> 33498194

Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases.

Brian C Monk1, Mikhail V Keniya1.   

Abstract

Antifungal drugs and antifungal agrochemicals have significant limitations. These include several unintended consequences of their use including the growing importance of intrinsic and acquired resistance. These problems underpin an increasingly urgent need to improve the existing classes of antifungals and to discover novel antifungals. Structural insights into drug targets and their complexes with both substrates and inhibitory ligands increase opportunity for the discovery of more effective antifungals. Implementation of this promise, which requires multiple skill sets, is beginning to yield candidates from discovery programs that could more quickly find their place in the clinic. This review will describe how structural biology is providing information for the improvement and discovery of inhibitors targeting the essential fungal enzyme sterol 14α-demethylase.

Entities:  

Keywords:  CYP51; antifungal drug discovery; azole agrochemicals; azole drugs; in silico screens; molecular docking; pharmacophore; sterol 14α-demethylase; structure-directed drug design

Year:  2021        PMID: 33498194      PMCID: PMC7908997          DOI: 10.3390/jof7020067

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  165 in total

Review 1.  Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

Authors:  Florent Morio; Cedric Loge; Bernard Besse; Christophe Hennequin; Patrice Le Pape
Journal:  Diagn Microbiol Infect Dis       Date:  2010-04       Impact factor: 2.803

2.  Infectious Disease. How to bolster the antifungal pipeline.

Authors:  David W Denning; Michael J Bromley
Journal:  Science       Date:  2015-03-26       Impact factor: 47.728

3.  Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer.

Authors:  Brian C Monk; Thomas M Tomasiak; Mikhail V Keniya; Franziska U Huschmann; Joel D A Tyndall; Joseph D O'Connell; Richard D Cannon; Jeffrey G McDonald; Andrew Rodriguez; Janet S Finer-Moore; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

4.  Novel Substrate Specificity and Temperature-Sensitive Activity of Mycosphaerella graminicola CYP51 Supported by the Native NADPH Cytochrome P450 Reductase.

Authors:  Claire L Price; Andrew G S Warrilow; Josie E Parker; Jonathan G L Mullins; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

Review 5.  Structural basis for conservation in the CYP51 family.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2010-06-11

6.  Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.

Authors:  Gustavo H Goldman; Márcia Eliana da Silva Ferreira; Everaldo dos Reis Marques; Marcela Savoldi; David Perlin; Steven Park; Patricio Christian Godoy Martinez; Maria Helena S Goldman; Arnaldo L Colombo
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

7.  The gut mycobiome of the Human Microbiome Project healthy cohort.

Authors:  Andrea K Nash; Thomas A Auchtung; Matthew C Wong; Daniel P Smith; Jonathan R Gesell; Matthew C Ross; Christopher J Stewart; Ginger A Metcalf; Donna M Muzny; Richard A Gibbs; Nadim J Ajami; Joseph F Petrosino
Journal:  Microbiome       Date:  2017-11-25       Impact factor: 14.650

8.  Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Authors:  Nicolas Lebouvier; Fabrice Pagniez; Young Min Na; Da Shi; Patricia Pinson; Mathieu Marchivie; Jean Guillon; Tarek Hakki; Rita Bernhardt; Sook Wah Yee; Claire Simons; Marie-Pierre Lézé; Rolf W Hartmann; Angélique Mularoni; Guillaume Le Baut; Isabelle Krimm; Ruben Abagyan; Patrice Le Pape; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2020-08-08
View more
  2 in total

1.  In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi.

Authors:  Mohamed A Soltan; Muhammad Alaa Eldeen; Nada Elbassiouny; Hasnaa L Kamel; Kareem M Abdelraheem; Hanaa Abd El-Gayyed; Ahmed M Gouda; Mohammed F Sheha; Eman Fayad; Ola A Abu Ali; Khalid Abd El Ghany; Dalia A El-Damasy; Khaled M Darwish; Sameh S Elhady; Ashraf E Sileem
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

2.  Correction: Monk, B.C.; Keniya, M.V. Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases. J. Fungi 2021, 7, 67.

Authors:  Brian C Monk; Mikhail V Keniya
Journal:  J Fungi (Basel)       Date:  2021-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.